Guidelines of management of musculoskeletal complications of hemophilia
Hemophilia is an X-linked heritable coagulopathy with an overall prevalence of approximately 1 in 10,000 individuals. The most common form is factor VIII deficiency (hemophilia A), which comprises approximately 80% of cases. Factor IX deficiency (hemophilia B), comprises approximately 20% of cases....
Main Author: | Mousa Mohammad Alhaosawi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Journal of Applied Hematology |
Subjects: | |
Online Access: | http://www.jahjournal.org/article.asp?issn=1658-5127;year=2014;volume=5;issue=3;spage=75;epage=85;aulast=Alhaosawi |
Similar Items
-
Target joint "new concept of identification"
by: Mousa Mohammad Alhaosawi
Published: (2015-01-01) -
Clinical Evaluation of the Joints of Patients with Hemophilia
by: Sezai Ozkan, et al.
Published: (2014-08-01) -
Study of musculoskeletal complications of hemophilia at a tertiary health-care center in Central India
by: Sujeet Mishra, et al.
Published: (2019-01-01) -
Musculoskeletal Changes in Hemophilia Patients Subsequent to COVID−19 Lockdown
by: Rubén Cuesta-Barriuso, et al.
Published: (2021-06-01) -
Manual therapy in the treatment of patients with hemophilia B and inhibitor
by: Rubén Cuesta-Barriuso, et al.
Published: (2018-01-01)